pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
CAR-T · news · pharmadog
← back to CAR-T
News · CAR-T
190
stories
May 7, 26
STAT+: Color me skeptical: Drinking gold is not an ALS cure
stat
May 6, 26
Consensus Viewpoints Offer Guidance in Rapidly Evolving Multiple Myeloma Management
onclive
May 1, 26
J&J axes pair of CAR-T therapies for lymphoma, citing evolving market
endpoints
Apr 30, 26
STAT+: Hair-raising trial results, and Servier’s M&A wishlist
stat
Apr 30, 26
STAT+: What does Akeso’s primo plenary spot say about its survival data?
stat
Apr 25, 26
Sanofi’s immunology reckoning; Lilly acquires in vivo CAR-T biotech; RevMed’s ‘Herceptin moment’; and more
endpoints
Apr 24, 26
STAT+: A biotech VC on what Eli Lilly saw in a struggling cancer startup for $3.2B
stat
Apr 23, 26
A CAR-T biotech’s dramatic turnaround, and drugmakers’ tactics to drive more scripts
stat
Dec 23, 25
Fierce Biotech Layoff Tracker 2026: Milestone shrinks HQ workforce during Cardamyst rollout
fiercebiotech
Dec 22, 25
Fierce Biotech Fundraising Tracker '26: VitriVax scores $87M; Ansa adds $71.5M series C
fiercebiotech
← prev
page 7 of 7
next →